Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women
| Yazar: | |
|---|---|
| Diğer Yazarlar: | |
| Materyal Türü: | Journal article |
| Dil: | English |
| Baskı/Yayın Bilgisi: |
Elsevier
1992
|
| _version_ | 1826309725809016832 |
|---|---|
| author | Early Breast Cancer Trialist's Collaborative Group |
| author2 | Abe, O |
| author_facet | Abe, O Early Breast Cancer Trialist's Collaborative Group |
| author_sort | Early Breast Cancer Trialist's Collaborative Group |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-07T07:40:00Z |
| format | Journal article |
| id | oxford-uuid:d539940b-a19d-4c7d-b734-2d33e804cabc |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T07:40:00Z |
| publishDate | 1992 |
| publisher | Elsevier |
| record_format | dspace |
| spelling | oxford-uuid:d539940b-a19d-4c7d-b734-2d33e804cabc2023-04-05T10:44:19ZSystemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 womenJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:d539940b-a19d-4c7d-b734-2d33e804cabcEnglishSymplectic Elements at OxfordElsevier1992Early Breast Cancer Trialist's Collaborative GroupAbe, OAbe, RAsaishi, KEnomoto, KHattori, TIno, YGray, RClarke, MCollins, RPeto, R |
| spellingShingle | Early Breast Cancer Trialist's Collaborative Group Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women |
| title | Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women |
| title_full | Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women |
| title_fullStr | Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women |
| title_full_unstemmed | Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women |
| title_short | Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women |
| title_sort | systemic treatment of early breast cancer by hormonal cytotoxic or immune therapy 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women |
| work_keys_str_mv | AT earlybreastcancertrialistscollaborativegroup systemictreatmentofearlybreastcancerbyhormonalcytotoxicorimmunetherapy133randomisedtrialsinvolving31000recurrencesand24000deathsamong75000women |